Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Atherosclerosis ; 212(1): 268-73, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20537649

ABSTRACT

OBJECTIVE: Genetic and dietary hyperhomocysteinemia has been found to decrease high density lipoproteins (HDL) and their apolipoprotein A1 (APOA1). To test the hypothesis that the presence of cysteine could normalize HDL levels in hyperhomocysteinemic cystathionine beta-synthase (Cbs)-deficient mice and that the inclusion of glycine would block this effect. METHODS: Lipids and HDL cholesterol were studied in Cbs-deficient mice and wild-type animals fed a low-methionine diet supplemented with cysteine and glycine and in Cbs-deficient mice on the same diet supplemented only with cysteine. RESULTS: Triglyceride and homocysteine levels were significantly decreased and increased, respectively in Cbs-deficient mice irrespective of treatment. However, plasma cholesterol, glucose and APOA1 were significantly decreased in homozygous Cbs-deficient mice when they received the cysteine and glycine-enriched beverage. This group of mice also showed decreased mRNA levels and increased hepatic content of APOA1 protein, the latter increase was observed in endothelial cells. A significant, inverse relationship was observed between plasma and hepatic APOA1 concentrations while a positive one was found between plasma levels of cysteine and APOA1. CONCLUSION: These data suggest an altered hepatic management of APOA1 and that cysteine may be involved in the control of this apolipoprotein at this level. Overall these findings represent a new aspect of dietary regulation of HDL at the hepatic transendothelial transport.


Subject(s)
Apolipoprotein A-I/blood , Biomarkers/blood , Cysteine/blood , Homocysteine/blood , Homocystinuria/blood , Hyperhomocysteinemia/blood , Lipid Metabolism , Liver/metabolism , Administration, Oral , Animals , Apolipoprotein A-I/genetics , Beverages , Blood Glucose/metabolism , Cholesterol, HDL/blood , Cysteine/administration & dosage , Disease Models, Animal , Glycine/administration & dosage , Homocystinuria/genetics , Hyperhomocysteinemia/genetics , Lipid Metabolism/genetics , Male , Mice , Mice, Knockout , RNA, Messenger/metabolism , Spain , Triglycerides/blood
2.
Atherosclerosis ; 197(1): 72-83, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17854812

ABSTRACT

BACKGROUND: Squalene is an intermediate of cholesterol biosynthesis which can be obtained from the diet where it is abundant, for example, in olive oil. The effect of this isoprenoid on the development of atherosclerosis was investigated on apoE-knockout mice. METHODS AND RESULTS: Two groups of animals, separated according to sex, were fed on standard chow diet: the control group receiving only vehicle and the second group an aqueous solution of squalene to provide a dose of 1g/kg/day in male and female mice. This treatment was maintained for 10 weeks. At the end of this period, plasma lipid parameters, oxidative stress markers and hepatic fat were measured as well as cross-sectional lesion area of aortic root in both groups. Data showed that in males squalene feeding reduced atherosclerotic lesion area independently of plasma lipids and activation of circulating monocytes. In contrast, squalene intake did not decrease lesion area in females, despite reducing plasma cholesterol and triglycerides, isoprostane and percentage of Mac-1 expressing white cells. In males, atherosclerotic lesion area was positively and significantly associated with hepatic fat content and the plasma triglycerides were also strongly associated with liver weight. CONCLUSIONS: These results indicate that administration of squalene modulates lesion development in a gender specific manner, and that accumulation of hepatic fat by liver is highly correlated with lesion progression in males. Hence, squalene administration could be used as a safe alternative to correct hepatic steatosis and atherosclerosis particularly in males.


Subject(s)
Apolipoproteins E/genetics , Atherosclerosis/drug therapy , Fatty Liver/drug therapy , Sex Characteristics , Squalene/pharmacology , Animals , Apolipoprotein A-I/blood , Apolipoprotein A-I/genetics , Apolipoprotein A-V , Apolipoproteins/genetics , Apolipoproteins/metabolism , Aryldialkylphosphatase/metabolism , Atherosclerosis/genetics , Atherosclerosis/pathology , Body Weight/drug effects , CD11b Antigen/metabolism , Cholesterol/blood , DNA-Binding Proteins/drug effects , Dinoprost/analogs & derivatives , Dinoprost/blood , Fatty Liver/genetics , Fatty Liver/pathology , Female , Liver/drug effects , Liver/metabolism , Liver/pathology , Liver X Receptors , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Orphan Nuclear Receptors , RNA, Messenger/metabolism , Receptors, Cytoplasmic and Nuclear/drug effects , Receptors, LDL/genetics , Scavenger Receptors, Class B/genetics , Triglycerides/blood
3.
Br J Nutr ; 97(4): 628-38, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17349074

ABSTRACT

The hypothesis that the unsaponifiable fraction of olive oil dramatically influences hepatic gene expression was tested in mice. Two olive oils, obtained from the same olive cultivar but by different technological procedures, were characterized to show that they differed mainly in terms of the composition/quantity of this unsaponifiable fraction. Using DNA microarrays, hepatic gene expression was analysed in apoE-deficient mice fed one of two isoenergetic, isonitrogenous diets containing either 10 % (w/w) olive oil or unsaponifiable fraction-enriched olive oil. To provide an initial screening of potential candidate genes involved in a differential response, only genes with remarkably modified expression (signal log2 ratio >3 or < - 3) were further considered. The eleven genes fulfilling these prerequisites were confirmed by quantitative RT-PCR, and then analysed in apoE-deficient mice with a C57BL/6J genetic background. Orosomucoid and serum amyloid A2 were upregulated (to variable extents depending on the genetic background) in the absence of hepatic steatosis and inflammation. Fabp5 and Mt2 were also strongly upregulated. Several proteases were highly suppressed by the unsaponifiable-enriched olive diet, independent of the genetic background. The findings indicate that change in the expression of these genes is a good marker of the intake of the unsaponifiable fraction of olive oil. The results highlight the important biological effects of the unsaponifiable fraction of olive oil. The term 'monounsaturated fatty acid-enriched oil' no longer appears appropriate for describing all the oils to which it is currently applied since it does not adequately reflect that they have different biological effects.


Subject(s)
Apolipoproteins E/deficiency , Dietary Fats, Unsaturated/pharmacology , Gene Expression Regulation/drug effects , Liver/metabolism , Plant Oils/pharmacology , Animals , Diet , Fatty Acids/analysis , Food Handling/methods , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Microarray Analysis , Olive Oil , Plant Oils/chemistry , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods
4.
Atherosclerosis ; 194(2): 372-82, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17141784

ABSTRACT

To test the hypothesis that extra virgin olive oils from different cultivars added to Western diets might behave differently than palm oil in the development of atherosclerosis, apoE-deficient mice were fed diets containing different cultivars of olive oil for 10 weeks. Female mice were assigned randomly to one of the following five groups: (1-4) fed chow diets supplemented with 0.15% (w/w) cholesterol and 20% (w/w) extra virgin olive oil from the Arbequina, Picual, Cornicabra, or Empeltre cultivars, and (5) fed a chow diet supplemented with 0.15% cholesterol and 20% palm oil. Compared to diets containing palm oil, a Western diet supplemented with one of several varieties of extra virgin olive oil decreased atherosclerosis lesions, reduced plaque size, and decreased macrophage recruitment. Unexpectedly, total plasma paraoxonase activity, apoA-I, plasma triglycerides, and cholesterol played minor roles in the regulation of differential aortic lesion development. Extra virgin olive oil induced a cholesterol-poor, apoA-IV-enriched lipoparticle that has enhanced arylesterase and antioxidant activities, which is closely associated with reductions in atherosclerotic lesions. Given the anti-atherogenic properties of extra virgin olive oil evident in animal models fed a Western diet, clinical trials are needed to establish whether these oils are a safe and effective means of treating atherosclerosis.


Subject(s)
Apolipoproteins A/metabolism , Apolipoproteins E/genetics , Atherosclerosis/physiopathology , Plant Oils/adverse effects , Animals , Aorta/pathology , Apolipoprotein A-I/blood , Apolipoproteins A/chemistry , Aryldialkylphosphatase/blood , Diet, Atherogenic , Disease Models, Animal , Female , Mice , Olive Oil , Palm Oil , Plant Oils/chemistry , Plant Oils/classification
5.
Hum Mol Genet ; 15(21): 3168-76, 2006 Nov 01.
Article in English | MEDLINE | ID: mdl-16984962

ABSTRACT

In human reproduction, hyperhomocysteinemia has been reported as a risk factor for early pregnancy loss and congenital birth defects. Hyperhomocysteinemia is also recognized as a cause of maternal obstetric complications such as preeclampsia. The role of plasma hyperhomocysteinemia in female fertility was examined using cystathionine beta synthase knockout (cbs KO) mice. Cbs KO females were infertile, showed alterations in the estrus cycle and an increased progesterone response during pseudo-pregnancy induction. Both cbs KO ovaries and ovulated oocytes showed no major morphological alterations. However, placental and uterine masses were decreased at day 18 of pregnancy and showed morphological abnormalities. In cbs-KO pregnant females, the number of uterine implantation sites was not decreased despite the low number of surviving embryos. Fertility was restored when cbs-deficient ovaries were transplanted to normal ovarectomized recipients. We detected an increased uterine expression of Grp78, a marker of endoplasmic reticulum stress, which was accompanied by the decreased levels of uterine cbs mRNA in both hyperhomocysteinemic heterozygous (fertile) and homozygous (non-fertile) females. Our results indicate that cbs -/- female infertility is a consequence of the uterine failure and demonstrate that uterine endoplasmic reticulum stress and cbs expression are not determinant of infertility, suggesting that uterine dysfunction is a consequence of either hyperhomocysteinemia or other factor(s) in the uterine environment of cbs -/- animals. In summary, these studies demonstrate the potential importance of homocysteine levels for uterine handling of embryos.


Subject(s)
Cystathionine beta-Synthase/genetics , Hyperhomocysteinemia/physiopathology , Infertility, Female/genetics , Uterus/physiopathology , Animals , Cystathionine beta-Synthase/physiology , Endoplasmic Reticulum/chemistry , Endoplasmic Reticulum/metabolism , Endoplasmic Reticulum Chaperone BiP , Estrous Cycle , Female , Heat-Shock Proteins/analysis , Hyperhomocysteinemia/genetics , Infertility, Female/enzymology , Infertility, Female/physiopathology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Molecular Chaperones/analysis , Pregnancy , Uterus/cytology
6.
J Biochem ; 140(3): 383-91, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16873395

ABSTRACT

Hydroxytyrosol is a phenol found in olive oil. To verify the effect of hydroxytyrosol on the development of atherosclerosis, two groups of apo E deficient male mice on a standard chow diet were used: the control group receiving only water, and the second group an aqueous solution of hydroxytyrosol in order to provide a dose of 10 mg/kg/day to each mouse. This treatment was maintained for 10 weeks. At the moment of sacrifice, blood was drawn and heart removed. Plasma lipids, apolipoproteins and monocyte Mac-1 expression were assayed as well as aortic atherosclerotic areas in both groups. Data showed no significant changes in HDL cholesterol, paraoxonase, apolipoprotein B or triglyceride levels. However, hydroxytyrosol administration decreased apolipoprotein A-I and increased total cholesterol, atherosclerotic lesion areas and circulating monocytes expressing Mac-1. The latter was highly correlated with lesion areas (r = 0.65, P < 0.01). These results indicate that administration of hydroxytyrosol in low cholesterol diets increases atherosclerotic lesion associated with the degree of monocyte activation and remodelling of plasma lipoproteins. Our data supports the concept that phenolic-enriched products, out of the original matrix, could be not only non useful but also harmful. Our results suggest that the formulation of possible functional foods should approximate as much as possible the natural environment in which active molecules are found.


Subject(s)
Apolipoprotein A-I/blood , Apolipoproteins E/deficiency , Coronary Artery Disease/pathology , Phenylethyl Alcohol/analogs & derivatives , Animals , Apolipoproteins B/blood , Aryldialkylphosphatase/blood , Cholesterol, HDL/blood , Coronary Artery Disease/chemically induced , DNA Primers , Macrophage-1 Antigen/genetics , Macrophage-1 Antigen/metabolism , Male , Mice , Monocytes/metabolism , Phenylethyl Alcohol/administration & dosage , Phenylethyl Alcohol/toxicity , Phenylethyl Alcohol/urine , Reverse Transcriptase Polymerase Chain Reaction , Triglycerides/blood
7.
Front Biosci ; 11: 955-67, 2006 Jan 01.
Article in English | MEDLINE | ID: mdl-16146786

ABSTRACT

The generation by genetic engineering of two murine models to investigate atherosclerosis, such as the apoE- and LDLr- deficient mice, is providing an extraordinaire knowledge of the effect of different nutrients on this complex disease. The present revision provides a comprehensive overview of the advances in this field that point to a remarkable complexity. While some controversies over puzzling results could be explained invoking potential nutrient interactions or different food sources of nutrients, it also appears that other factors such as sex, genetic background or immunological status are emerging as generators of differential responses to nutrients during the atherosclerotic process.


Subject(s)
Atherosclerosis/genetics , Atherosclerosis/pathology , Disease Models, Animal , Genetic Engineering , Alcohol Drinking , Allergy and Immunology , Animals , Antioxidants/chemistry , Apolipoproteins E/genetics , Arginine/chemistry , Arteriosclerosis , Ascorbic Acid/chemistry , Cell Proliferation , Dietary Fats , Energy Metabolism , Fatty Acids, Monounsaturated/metabolism , Fatty Acids, Unsaturated/metabolism , Genetic Variation , Genomics , Homocysteine/chemistry , Insulin Resistance , Iron/metabolism , Magnesium/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Models, Biological , Models, Genetic , Phytosterols/chemistry , Phytosterols/metabolism , Receptors, LDL/metabolism , Sex Factors , Sodium/metabolism , Taurine/chemistry , Vitamin E/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...